Article info

Download PDFPDF

Original research
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma

Authors

  1. Correspondence to Dr David Tai, 4/F, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610; david.tai.w.m{at}singhealth.com.sg; Dr Joe Yeong, 61, Biopolis Drive Proteos, Singapore, 138673; yeongps{at}imcb.a-star.edu.sg; Professor Tony Kiat Hon Lim, Dept of Anatomical Pathology, Singapore General Hospital, 20 College Road, Academia, Level 10, Diagnostics Tower, Singapore, 169856; lim.kiat.hon{at}singhealth.com.sg
View Full Text

Citation

Ng HHM, Lee RY, Goh S, et al
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma

Publication history

  • Accepted July 16, 2020
  • First published August 26, 2020.
Online issue publication 
August 26, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.